Skip to content

Early warning and supportive intervention in the elderly with mild cognitive impairment based on family perspective

Early warning and supportive intervention in the elderly with mild cognitive impairment based on family perspective

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075195
Enrollment
Unknown
Registered
2023-08-29
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment, MCI

Interventions

Intervention group:On the basis of control group, risk identification intervention and targeted program were adopted
Control group:Health education

Sponsors

Nanjing University of Chinese Medicine; Nanjing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 60~80 years old; (2) years of education =6 years; (3) mini-mental state examination (MMSE)=24 points; (4) Montreal Cognitive Assessment Scale (MoCA) score < 26 points, if the years of education =12 years, score plus 1 point; (5) The Clinical Dementia Rating Scale (CDR) score was 0.5, excluding dementia patients; (6) The Auditory verb learn test-Huashan version (AVLT-H) score is less than 1.5 standard deviations lower than the normal control. (7) Activities of daily living (ADL) score =23 points; (8) normal visual hearing, able to conduct neuropsychological tests; (9) Voluntary participation and signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) Diagnosis of Alzheimer's disease or other types of dementia. (2) Patients with a history of cerebrovascular disease, including ischemic cerebrovascular disease, hemorrhagic cerebrovascular disease, and neurological diseases such as hemiplegia and aphasia. (3) Patients with secondary metabolic disorders caused by certain endocrine, genetic and nervous system diseases, and patients with metabolic diseases caused by drugs. (4) Critically ill patients, patients with other central nervous system injury diseases or history, such as brain trauma, encephalitis, epilepsy, tumors, infections, severe liver and kidney dysfunction, blood system diseases, central nervous system demyelinating diseases, central nervous system degenerative diseases, etc. (5) have received treatment to improve cognitive function in the past 3 months, or are participating in other clinical trials; (6) Patients with cardiac pacemakers.

Design outcomes

Primary

MeasureTime frame
cognitive function;

Secondary

MeasureTime frame
sleep quality;quality of life;

Countries

China

Contacts

Public ContactYamei Bai;Xiujun Guo

Nanjing University of Chinese Medicine; Nanjing Hospital of Traditional Chinese Medicine

czbym@njucm.edu.cn+86 138 1506 7378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026